ALOGLIPTIN AND METFORMIN HYDROCHLORIDE (alogliptin and metformin hydrochloride) by Takeda is 2 diabetes mellitus: alogliptin, a selective inhibitor of dpp-4, and metformin hcl, a member of the biguanide class. Approved for type 2 diabetes mellitus, type 1 diabetes mellitus.
Drug data last refreshed 1mo ago
2 diabetes mellitus: alogliptin, a selective inhibitor of DPP-4, and metformin HCl, a member of the biguanide class. Alogliptin Increased concentrations of the incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are released into the…
Worked on ALOGLIPTIN AND METFORMIN HYDROCHLORIDE at Takeda? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Renal or Hepatic Impairment or Advanced Age"